Phio Pharmaceuticals Corp.

PHIO | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.01

-$0.02 (-1.94%)

At close: Sep 21, 2026, 4:00 PM ET

$1.06

+$0.05 (+4.95%)

Pre-market: Sep 22, 2026, 6:21 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	-8.7M	-7.15M	-10.83M	-11.48M	-13.29M	-8.79M
Depreciation & Amortization	3K	35K	184K	193K	75K	72K
Stock-Based Compensation	481K	147K	303K	414K	480K	136K
Other Working Capital	52K	266K	-414K	-1.75M	1.44M	-246K
Other Non-Cash Items	n/a	-6K	126K	n/a	117K	111K
Deferred Income Tax	n/a	n/a	n/a	n/a	-233K	n/a
Change in Working Capital	235K	-138K	-536K	-1.26M	990K	-327K
Operating Cash Flow	-7.98M	-7.11M	-10.75M	-12.13M	-11.86M	-8.8M
Capital Expenditures	-12K	-1K	-5K	-121K	-51K	-19K
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	9K	n/a	n/a	n/a	n/a
Investing Cash Flow	-12K	8K	-5K	-121K	-51K	-19K
Debt Repayment	n/a	n/a	n/a	n/a	n/a	204K
Common Stock Repurchased	n/a	-1K	-11K	n/a	n/a	-15K
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-30K	-5K	-26K	-28K	2.15M	3.85M
Financial Cash Flow	23.64M	4M	7.41M	-26K	21.72M	16.13M
Net Cash Flow	15.65M	-3.11M	-3.34M	-12.28M	9.81M	7.31M
Free Cash Flow	-7.99M	-7.11M	-10.75M	-12.25M	-11.91M	-8.82M
Adj. Free Cash Flow	-8.47M	-7.26M	-11.06M	-12.66M	-12.39M	-8.96M
Maintenance CapEx	-12K	-1K	-5K	-121K	-51K	-19K
Growth CapEx	n/a	n/a	n/a	n/a	n/a	n/a
Owner Earnings	-7.99M	-7.11M	-10.75M	-12.25M	-11.91M	-8.82M